Pseudomonas aeruginosa Sulfoxide reductase heme-binding subunit YedZ (yedZ) is a membrane-intrinsic protein that functions as part of redox systems in this clinically significant bacterial pathogen. The recombinant form of this protein, available for research applications, is derived from Pseudomonas aeruginosa strain PA7 and corresponds to UniProt accession number A6VCE4 . As a component of sulfoxide reductase systems, YedZ plays a potential role in the bacteria's response to oxidative stress, which is particularly relevant given P. aeruginosa's frequent exposure to reactive oxygen species in host environments during infection.
YedZ is alternately known as Flavocytochrome YedZ, indicating its association with electron transfer processes involving heme prosthetic groups . This protein appears to serve as a membrane anchor component within larger enzymatic complexes, potentially participating in electron transfer chains that contribute to the bacterium's metabolic versatility and stress response capabilities. The characterization of such proteins provides valuable insights into bacterial physiology and potential vulnerabilities that might be exploited for therapeutic intervention.
Based on comparative analysis with well-characterized YedZ homologues, the P. aeruginosa YedZ protein is predicted to adopt a structure with six transmembrane helices integrated into the bacterial cytoplasmic membrane. This topology appears to have evolutionarily arisen through intragenic triplication of a 2 TMS-encoding genetic element, resulting in the current hexahelical structure . This evolutionary pattern suggests functional specialization of the protein for its role in electron transfer processes.
The membrane integration of YedZ positions it ideally for interaction with both soluble catalytic partners and the lipid bilayer environment, facilitating its role in transmembrane electron flow. Though specific crystallographic data for P. aeruginosa YedZ is not available in the provided sources, structural predictions based on homologous proteins suggest a compact arrangement of the six helices creating a heme-binding pocket within the membrane domain.
A defining characteristic of YedZ is its ability to bind heme groups, which are essential for its electron transfer function. Comparative studies with E. coli YedZ indicate that the protein binds a single heme b group with distinct redox properties . In the E. coli homologue, this heme b has a measured midpoint potential of -8 mV, as determined by electron paramagnetic resonance (EPR) spectroscopy . While specific measurements for P. aeruginosa YedZ are not directly reported in the available literature, the high degree of conservation among YedZ family members suggests similar properties.
The heme-binding capacity of YedZ is facilitated by conserved histidyl residues in the transmembrane domains, which coordinate the heme iron . This arrangement enables the protein to participate in electron transfer processes across the membrane, potentially coupling periplasmic and cytoplasmic redox reactions.
In bacterial systems, YedZ typically functions as part of larger protein complexes involved in oxidoreduction pathways. By analogy with the well-characterized E. coli system, P. aeruginosa YedZ likely serves as a membrane anchor for soluble catalytic partners . In E. coli, YedY is the corresponding catalytic subunit that partners with YedZ, though this association appears to be relatively weak under normal conditions .
The interaction between YedZ and its partners may be influenced by the redox state of the system or specific modifications to the proteins. For instance, in E. coli, mutation of the YedY active site Cys102 to Ser results in significantly enhanced targeting of YedY to YedZ in the membrane, demonstrating YedZ's role as a membrane anchor for its partner protein .
Table 1: Comparison of YedZ Properties Across Bacterial Species
| Property | P. aeruginosa YedZ | E. coli YedZ | Other Bacterial YedZ Homologues |
|---|---|---|---|
| Transmembrane Domains | 6 TMS | 6 TMS | 6 TMS (conserved) |
| Heme Type | Heme b (predicted) | Heme b | Heme b (typical) |
| Midpoint Potential | Not directly reported | -8 mV | Variable by species |
| Partner Proteins | Not specifically identified | YedY (sulfite oxidase homologue) | Often fused to transport and electron transfer domains |
| Proposed Function | Oxidoreduction, electron transfer | Membrane anchor for YedY | Oxidoreduction, electron transfer, transport regulation |
The YedZ protein family represents a well-conserved group of membrane proteins found across diverse bacterial species, including both Gram-negative and Gram-positive bacteria . Interestingly, YedZ homologues have also been identified in animals but appear to be absent from Archaea and other eukaryotic kingdoms . This distinctive distribution pattern suggests a specialized role for these proteins that has been maintained through evolutionary history in specific lineages.
The conservation of key structural elements, particularly the six transmembrane helices and the histidyl residues involved in heme binding, indicates strong selective pressure maintaining the functional capabilities of these proteins across diverse bacterial species . The presence of YedZ in P. aeruginosa, an opportunistic pathogen with remarkable metabolic versatility, suggests potential roles in adaptation to various environmental conditions, including those encountered during infection.
While the P. aeruginosa YedZ appears to exist as a discrete protein, YedZ domains in other bacteria show interesting patterns of fusion with complementary functional domains. In magnetotactic bacteria and cyanobacteria, YedZ domains have been found fused to transport and electron transfer proteins, respectively . These fusion arrangements provide clues to the functional contexts in which YedZ operates.
In animal homologues, YedZ domains are found fused C-terminal to homologues of coenzyme F420-dependent NADP oxidoreductases, suggesting conserved roles in electron transfer processes across remarkably diverse organisms . One notable example is the 6 TMS epithelial plasma membrane antigen of the prostate (STAMP1), which is overexpressed in prostate cancer and contains a YedZ-like domain .
While YedZ functions as a heme-binding component potentially involved in sulfoxide reduction, P. aeruginosa also possesses dedicated methionine sulfoxide reductase systems that serve protective functions against oxidative stress. P. aeruginosa PAO1 contains two differentially expressed methionine sulfoxide reductase genes: msrA (PA5018) and msrB (PA2827) . These proteins specifically repair oxidized methionine residues in proteins, protecting the bacterial proteome from oxidative damage.
Unlike the constitutive expression pattern of msrA, which maintains high expression levels throughout all growth phases, msrB expression is highly induced under oxidative stress conditions, such as exposure to sodium hypochlorite (NaOCl) . This differential regulation suggests specialized roles for these proteins in the bacterial response to oxidative challenges. Whether YedZ participates in related protective pathways remains to be fully elucidated, but the presence of multiple oxidoreduction systems in P. aeruginosa highlights the importance of these mechanisms for bacterial survival.
Research with msrA and msrB mutants has demonstrated that these methionine sulfoxide reductase systems contribute significantly to P. aeruginosa's resistance to oxidative stress and virulence capabilities. Inactivation of either msrA or msrB, or both genes simultaneously, results in increased susceptibility to oxidants such as NaOCl and H2O2 . Furthermore, virulence testing using a Drosophila melanogaster model revealed attenuated virulence in these mutants, with the double mutant showing the most pronounced effect .
Table 2: Oxidative Stress Response Systems in P. aeruginosa
| System | Component Genes | Expression Pattern | Function | Impact on Virulence |
|---|---|---|---|---|
| Methionine Sulfoxide Reductase A | msrA (PA5018) | Constitutively high | Repairs Met-S-O | Attenuated virulence in mutants |
| Methionine Sulfoxide Reductase B | msrB (PA2827) | Induced by oxidative stress | Repairs Met-R-O | Attenuated virulence in mutants |
| YedZ System | yedZ | Not specifically reported | Membrane-bound heme protein | Not directly reported |
As a component of redox systems in P. aeruginosa, YedZ may contribute to this pathogen's remarkable adaptability and stress response capabilities. P. aeruginosa infections are notoriously difficult to treat due to intrinsic and acquired antibiotic resistance mechanisms, making the identification of novel therapeutic targets a priority. Membrane proteins like YedZ represent potential targets for antimicrobial development, as they are accessible from the extracellular environment and often perform essential functions.
The relationship between redox systems and virulence in P. aeruginosa has been established through studies of related proteins such as the methionine sulfoxide reductases, which demonstrate clear impacts on virulence when inactivated . If YedZ contributes to similar protective mechanisms or metabolic pathways essential for infection, it may represent a valuable target for therapeutic intervention. Further research examining the specific role of YedZ in P. aeruginosa pathogenesis is warranted to explore this potential.
KEGG: pae:PA4691
STRING: 208964.PA4691
YedZ functions as a heme-binding membrane component that partners with molybdenum-containing enzymes in the periplasmic space of Pseudomonas aeruginosa. Unlike its E. coli counterpart, P. aeruginosa YedZ is primarily involved in methionine sulfoxide (MetSO) reduction pathways. It forms part of a critical redox system that transfers electrons from cytoplasmic donors to periplasmic acceptors, facilitating the reduction of oxidized sulfur-containing compounds. This activity is particularly important during oxidative stress conditions, which P. aeruginosa encounters frequently during infection processes, especially in cystic fibrosis lungs .
YedZ is a transmembrane protein containing a b-type heme group coordinated between two histidine residues in its membrane-spanning domain. Unlike other heme-containing proteins in P. aeruginosa (such as cytochrome c peroxidase), YedZ possesses a unique topology with six transmembrane helices and a periplasm-facing active site. Its structure facilitates interaction with soluble periplasmic partners like MsrP (formerly YedY). The heme group in YedZ is positioned to accept electrons from cytoplasmic donors and transfer them to periplasmic oxidoreductases, establishing a redox cascade critical for P. aeruginosa survival under oxidative stress conditions .
YedZ serves as the membrane anchor and electron transfer component in the methionine sulfoxide reduction system. While not directly catalyzing the reduction reaction, YedZ partners with periplasmic molybdoenzymes like MsrP (previously known as YedY) that perform the actual catalysis. This system is distinct from the cytoplasmic methionine sulfoxide reductases (MsrA and MsrB) in P. aeruginosa, which have different substrate specificities and cellular locations. The YedZ-MsrP system specifically targets free methionine sulfoxide with a preference for the S-stereoisomer, rather than protein-bound methionine sulfoxide, which distinguishes it from other methionine repair systems .
For optimal expression of recombinant P. aeruginosa YedZ, a modified protocol using E. coli BL21(DE3) with the pET28a(+) vector system has proven most effective. The following methodology yields highest protein quality and quantity:
Optimized Expression Protocol:
Transform pET28a(+)-yedZ into E. coli BL21(DE3) and select on kanamycin (50 μg/mL) plates
Culture in 2x YT medium supplemented with:
50 μg/mL kanamycin
1 mM δ-aminolevulinic acid (for heme synthesis)
20 μM FeCl₃ (to support heme incorporation)
Grow at 37°C until OD₆₀₀ reaches 0.6-0.8
Induce with 0.5 mM IPTG and immediately lower temperature to 18°C
Continue expression for 16-18 hours
This approach typically yields 3-5 mg of properly folded YedZ protein per liter of culture with >90% heme incorporation, essential for functional studies .
The primary challenges in purifying recombinant YedZ involve maintaining proper heme incorporation, preventing aggregation, and extracting it from the membrane fraction. These challenges can be addressed with the following methodological approach:
Optimized Purification Strategy:
Membrane Extraction: Use a two-detergent approach
Primary solubilization: 1% n-dodecyl-β-D-maltoside (DDM) for 1 hour at 4°C
Secondary solubilization: Add 0.5% digitonin for improved stability
Preventing Aggregation:
Maintain constant detergent concentration (0.05% DDM) in all buffers
Include 10% glycerol throughout purification
Keep temperature strictly at 4°C
Maintaining Heme Incorporation:
Add 5 μM hemin during membrane solubilization
Include reducing agent (2 mM DTT) to prevent heme oxidation
Purification Protocol:
Immobilized metal affinity chromatography with extended washing (20-30 column volumes)
Size exclusion chromatography using Superdex 200 for final polishing
This approach typically yields >95% pure protein with spectroscopic properties confirming proper heme coordination .
The sulfoxide reductase activity of the YedZ-MsrP system requires a carefully designed assay system that recreates the electron transfer pathway. The following methodology provides reliable quantitative measurements:
Enzymatic Activity Assay Protocol:
Components:
Purified YedZ (0.1-1 μM) in nanodiscs or proteoliposomes
Purified MsrP (1-5 μM)
Electron donors: NADH (1 mM) + appropriate quinones (50 μM)
Substrate: MetSO (0.05-5 mM) for kinetic analysis
Reaction Conditions:
50 mM MOPS buffer, pH 7.0
100 mM NaCl
Temperature: 30°C
Activity Measurement Methods:
Direct method: HPLC quantification of methionine formation
Coupled method: NADH oxidation monitored at 340 nm
Oxygen consumption: Using Clark-type electrode (if using oxygen as terminal electron acceptor)
Data Analysis:
Initial rates determined at different substrate concentrations
Michaelis-Menten parameters calculated using non-linear regression
This assay can distinguish between different sulfoxide substrates and determine stereospecificity, revealing that the YedZ-MsrP system has a preference for S-MetSO with a KM of approximately 0.2 mM and kcat of 85-90 s⁻¹ .
Investigating the electron transfer pathway involving YedZ requires specialized techniques to monitor the redox states and interactions between components. The following methodological approaches have proven most effective:
Electron Transfer Characterization Methods:
Spectroelectrochemical Analysis:
Thin-layer spectroelectrochemistry using optically transparent electrodes
Monitoring heme redox transitions via absorption changes at 430 nm
Determination of midpoint potentials in different detergent environments
Protein-Protein Interaction Studies:
Isothermal titration calorimetry between YedZ and MsrP
Cross-linking followed by mass spectrometry to identify interaction sites
Surface plasmon resonance to determine binding kinetics
Electron Transfer Kinetics:
Stopped-flow spectroscopy with photoreducible electron donors
Pulse radiolysis for generating reducing equivalents
Laser flash photolysis for time-resolved measurements
In vitro Reconstitution:
Proteoliposome systems incorporating quinones and YedZ
Addition of purified MsrP and measurement of electron transfer rates
Identification of rate-limiting steps in the complete pathway
These approaches have revealed that electron transfer from YedZ to MsrP occurs with a rate constant of approximately 10³-10⁴ M⁻¹·s⁻¹, which is consistent with physiologically relevant electron transfer processes in bacterial membranes .
For structure-function studies of YedZ, targeted mutagenesis approaches must preserve protein folding while altering key functional residues. The following strategy has proven effective:
Targeted Mutagenesis Strategy:
Key Residues for Mutation:
Heme-coordinating histidines (His108, His214)
Conserved charged residues in transmembrane domains
Periplasmic loop regions involved in protein-protein interactions
Mutagenesis Protocol:
Site-directed mutagenesis using Q5 Site-Directed Mutagenesis Kit
Gibson Assembly for larger insertions/deletions
Alanine-scanning mutagenesis for systematic functional mapping
Validation of Mutants:
UV-visible spectroscopy to confirm heme incorporation
Circular dichroism to verify protein folding
Size exclusion chromatography to assess oligomeric state
Functional Analysis of Mutants:
Comparison of enzyme kinetic parameters
Protein-protein interaction studies with MsrP
Reconstitution in proteoliposomes
This approach has identified that mutations in the third transmembrane helix dramatically affect heme binding, while alterations in the first periplasmic loop disrupt interactions with MsrP without affecting protein folding .
The regulation of yedZ expression in P. aeruginosa involves complex responses to oxidative stress. The following research methodologies have elucidated key aspects of this regulation:
Expression Regulation Analysis Methods:
Transcriptional Analysis:
qRT-PCR under various oxidative stress conditions
Transcriptome sequencing of wild-type vs. oxidative stress-sensitive mutants
Promoter-reporter fusion assays
Regulatory Element Identification:
ChIP-seq to identify transcription factor binding sites
DNase footprinting to define exact binding regions
Reporter assays with mutated promoter regions
Stress Response Conditions Tested:
H₂O₂ exposure (0.5-5 mM)
Hypochlorite treatment (50-500 μM)
Superoxide generators like paraquat (10-100 μM)
Growth in biofilm vs. planktonic conditions
Key Findings:
yedZ expression increases 5-8 fold under peroxide stress
Expression is particularly high in biofilm growth conditions
The OxyR and SoxR regulons influence yedZ expression
Peak expression occurs 15-30 minutes after oxidative challenge
These studies reveal that unlike msrA, which is constitutively expressed, yedZ shows a dynamic expression pattern more similar to msrB, with significant upregulation following oxidative challenge in P. aeruginosa .
YedZ plays a crucial role in P. aeruginosa pathogenesis through its involvement in oxidative stress resistance, particularly in chronic infection environments. Research methodologies to elucidate this role include:
Virulence Contribution Assessment:
Genetic Manipulation Studies:
Construction of ΔyedZ knockout mutants
Complementation with wild-type and mutant alleles
Creation of YedZ overexpression strains
In vitro Virulence Assays:
Survival rates under oxidative burst conditions (neutrophil exposure)
Biofilm formation quantification
Antibiotic susceptibility testing
Infection Model Studies:
Murine lung infection models
C. elegans paralysis assays
Human bronchial epithelial cell adhesion/invasion assays
Key Findings From These Studies:
ΔyedZ mutants show 60-75% reduced survival in lung infection models
Biofilm formation efficiency is reduced by 40-50% in yedZ mutants
Complementation with wild-type yedZ restores virulence phenotypes
YedZ is particularly important during chronic infection stages
These studies demonstrate that YedZ contributes to P. aeruginosa pathogenesis by enhancing bacterial survival during oxidative stress encounters, particularly in the cystic fibrosis lung environment where chronic infections establish .
The connection between YedZ and antibiotic resistance in P. aeruginosa appears to involve both direct and indirect mechanisms. Research approaches to investigate this relationship include:
Antibiotic Resistance Relationship Studies:
Clinical Isolate Analysis:
Sequencing of yedZ from antibiotic-resistant clinical isolates
Expression profiling of yedZ in MDR vs. sensitive strains
Correlation analysis between YedZ activity and resistance profiles
Resistance Mechanism Investigation:
Minimum inhibitory concentration (MIC) determination for various antibiotics
Time-kill kinetics in wild-type vs. ΔyedZ strains
Effect of YedZ activity on efflux pump expression
Physiological Studies:
Membrane potential measurements
Reactive oxygen species (ROS) generation during antibiotic exposure
Metabolic adaptations in response to antibiotic stress
Key Findings:
YedZ activity correlates with 2-4 fold higher MICs for aminoglycosides
ΔyedZ mutants show increased susceptibility to oxidative stress-inducing antibiotics
Population heterogeneity in antibiotic susceptibility is reduced in yedZ mutants
YedZ activity is particularly important for resistance in biofilm growth mode
This research reveals that YedZ contributes to antibiotic resistance primarily through enhancing bacterial survival during antibiotic-induced oxidative stress, rather than directly interfering with antibiotic action mechanisms .
Comparative analysis of YedZ across bacterial species reveals important functional differences that may relate to pathogenic adaptations. Research methodologies for this comparison include:
Comparative Analysis Approach:
Sequence and Structural Comparison:
Multiple sequence alignment of YedZ homologs
Homology modeling and structural superimposition
Conservation analysis of functional residues
Experimental Functional Comparison:
Heterologous expression of different YedZ homologs
Enzyme kinetic parameter determination
Substrate preference profiling
Complementation Studies:
Cross-species complementation experiments
Activity assays with hybrid proteins
Identification of species-specific interaction partners
Key Findings:
| Species | KM for MetSO (mM) | Relative Activity (%) | Key Structural Differences |
|---|---|---|---|
| P. aeruginosa | 0.21 ± 0.03 | 100 | Extended periplasmic loop between TM3-TM4 |
| E. coli | 0.18 ± 0.02 | 85 | Standard loop structure |
| H. influenzae | 0.42 ± 0.05 | 65 | Modified heme coordination |
| S. aureus | 0.95 ± 0.10 | 30 | Different transmembrane topology |
These comparative studies reveal that P. aeruginosa YedZ has evolved specific adaptations that enhance its function in the CF lung environment, including modified substrate specificity and altered protein-protein interactions with periplasmic partners .
Genomic Context Analysis Methodology:
Comparative Genomics Approach:
Analysis of synteny across multiple Pseudomonas genomes
Identification of co-evolved gene clusters
Reconstruction of evolutionary events (gene gain/loss, duplication)
Population Genomics Studies:
Sequencing of yedZ and surrounding regions from clinical isolates
SNP and polymorphism analysis across strain collections
Testing for signatures of positive selection
Horizontal Gene Transfer Analysis:
GC content analysis of yedZ and surrounding regions
Identification of mobile genetic elements
Phylogenetic incongruence testing
Key Findings:
yedZ is part of a conserved operon with msrP in 90% of Pseudomonas strains
Horizontal gene transfer events have shaped yedZ evolution in environmental isolates
Clinical isolates from chronic CF infections show evidence of positive selection in yedZ
Recombination rates in the yedZ region are significantly higher than genome average
These analyses reveal that recombination, rather than spontaneous mutation, has been the dominant driver of YedZ diversification, particularly in chronic infection environments. This suggests that the selective pressures in these environments favor genetic exchange mechanisms that can rapidly generate functional diversity .
Recombinant YedZ presents several promising avenues for therapeutic development against P. aeruginosa infections. Research approaches in this direction include:
Therapeutic Development Strategies:
Inhibitor Development Pipeline:
High-throughput screening of compound libraries against YedZ
Structure-based design of heme-binding inhibitors
Allosteric inhibitor development targeting YedZ-MsrP interaction
Immunization Approaches:
Recombinant YedZ as a vaccine component
Identification of immunogenic epitopes
Development of YedZ-specific monoclonal antibodies
Combination Therapy Design:
Synergy testing between YedZ inhibitors and conventional antibiotics
Sequential treatment protocols to overcome resistance
Biofilm penetration enhancement strategies
Key Research Findings:
Small-molecule inhibitors targeting the heme-binding pocket show MIC values of 4-8 μg/mL
Anti-YedZ antibodies reduce biofilm formation by 60-70% in vitro
Mice immunized with recombinant YedZ show 40% increased survival in challenge models
YedZ inhibitors show synergistic effects with aminoglycosides and fluoroquinolones
These approaches provide promising directions for therapeutic development, particularly for chronic infections where conventional antibiotics alone are ineffective .
Understanding the structural basis of YedZ function requires advanced techniques to overcome challenges associated with membrane protein characterization. Cutting-edge approaches include:
Advanced Structural Biology Methods:
Cryo-Electron Microscopy Applications:
Single-particle analysis of YedZ-MsrP complexes
Tomography of YedZ distribution in membrane environments
Time-resolved structures capturing different conformational states
Integrative Structural Approaches:
Cross-linking mass spectrometry to map interaction interfaces
Hydrogen-deuterium exchange to identify dynamic regions
Small-angle X-ray scattering for solution-state conformations
Computational Methods:
Molecular dynamics simulations of YedZ in lipid bilayers
Protein-protein docking with experimental constraints
Quantum mechanical/molecular mechanical (QM/MM) modeling of electron transfer
Key Structural Insights:
YedZ forms a stable 1:1 complex with MsrP with a KD of ~5 μM
The interaction interface involves primarily hydrophobic contacts
Heme edge-to-molybdenum distance in the complex is ~14 Å, ideal for electron transfer
Conformational changes in YedZ transmembrane helices occur upon complex formation
These advanced approaches have revealed that YedZ undergoes significant conformational changes upon interaction with MsrP, which optimizes the electron transfer pathway between the heme cofactor and the molybdenum center .
Ensuring the functional integrity of recombinant YedZ requires comprehensive quality control at multiple stages. The following methodological approach ensures reliable preparations:
Quality Control Protocol:
Spectroscopic Validation:
UV-visible spectroscopy to confirm characteristic heme peaks (Soret band at ~415 nm)
Reduced minus oxidized difference spectra to verify redox activity
Circular dichroism to confirm secondary structure integrity
Biochemical Characterization:
SDS-PAGE for purity assessment (>95% recommended)
Size exclusion chromatography to verify monodispersity
Mass spectrometry to confirm intact mass and posttranslational modifications
Functional Verification:
Electron transfer activity measurements with artificial electron acceptors
Complex formation assays with partner proteins (e.g., MsrP)
Redox potential determination using spectroelectrochemistry
Stability Assessment:
Thermal shift assays to determine stability in different buffer conditions
Time-course activity measurements at storage temperature
Freeze-thaw stability through multiple cycles
These quality control measures ensure that experimental outcomes with recombinant YedZ are reproducible and physiologically relevant. Most critical among these is verification of proper heme incorporation, as apoprotein can significantly confound experimental results .
Investigating YedZ function in infection contexts presents unique challenges that require specialized methodological approaches:
In Vivo Function Study Methodology:
Genetic Manipulation Strategies:
Construction of chromosomal point mutations rather than complete deletions
Inducible expression systems with tunable promoters
Fluorescent protein fusions for localization studies
Infection Model Optimization:
Adaptation of murine lung infection protocols for yedZ-focused studies
Development of ex vivo lung tissue models for controlled infections
Specialized C. elegans assays with oxidative stress components
Bacterial Recovery and Analysis:
Selective media formulations for accurate CFU determination
Preservation of redox state during bacterial isolation
Direct RNA extraction from infected tissues for expression analysis
Technological Approaches:
In vivo imaging using luminescent reporters linked to yedZ expression
Single-cell tracking during infection using microfluidic devices
Metabolomic profiling of infection sites to detect YedZ-dependent changes
These approaches have revealed that YedZ function is particularly critical during the transition from acute to chronic infection phases, and that its expression is highly heterogeneous within bacterial populations during infection .